Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Campylobacter concisus UPF0210 protein Ccon26_06850 (Ccon26_06850) CSB-YP421896CWA
CSB-EP421896CWA
CSB-BP421896CWA
CSB-MP421896CWA
CSB-EP421896CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus tRNA modification GTPase MnmE (mnmE) CSB-YP421897CWA
CSB-EP421897CWA
CSB-BP421897CWA
CSB-MP421897CWA
CSB-EP421897CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus Cysteine--tRNA ligase (cysS) CSB-YP421898CWA
CSB-EP421898CWA
CSB-BP421898CWA
CSB-MP421898CWA
CSB-EP421898CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus Pantothenate synthetase (panC) CSB-YP421899CWA
CSB-EP421899CWA
CSB-BP421899CWA
CSB-MP421899CWA
CSB-EP421899CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus SsrA-binding protein (smpB) CSB-YP421900CWA
CSB-EP421900CWA
CSB-BP421900CWA
CSB-MP421900CWA
CSB-EP421900CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus Aspartate carbamoyltransferase (pyrB) CSB-YP421901CWA
CSB-EP421901CWA
CSB-BP421901CWA
CSB-MP421901CWA
CSB-EP421901CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus Imidazoleglycerol-phosphate dehydratase (hisB) CSB-YP421902CWA
CSB-EP421902CWA
CSB-BP421902CWA
CSB-MP421902CWA
CSB-EP421902CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus Prolipoprotein diacylglyceryl transferase (lgt), partial CSB-YP421903CWA1
CSB-EP421903CWA1
CSB-BP421903CWA1
CSB-MP421903CWA1
CSB-EP421903CWA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus Uridylate kinase (pyrH) CSB-YP421904CWA
CSB-EP421904CWA
CSB-BP421904CWA
CSB-MP421904CWA
CSB-EP421904CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus (3R)-hydroxymyristoyl-[acyl-carrier-protein] dehydratase CSB-YP421905CWA
CSB-EP421905CWA
CSB-BP421905CWA
CSB-MP421905CWA
CSB-EP421905CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus Undecaprenyl-diphosphatase (uppP), partial CSB-YP421906CWA
CSB-EP421906CWA
CSB-BP421906CWA
CSB-MP421906CWA
CSB-EP421906CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus Translation initiation factor IF-1 (infA) CSB-YP421907CWA
CSB-EP421907CWA
CSB-BP421907CWA
CSB-MP421907CWA
CSB-EP421907CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus 30S ribosomal protein S8 (rpsH) CSB-YP421908CWA
CSB-EP421908CWA
CSB-BP421908CWA
CSB-MP421908CWA
CSB-EP421908CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter concisus 50S ribosomal protein L16 (rplP) CSB-YP421909CWA
CSB-EP421909CWA
CSB-BP421909CWA
CSB-MP421909CWA
CSB-EP421909CWA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Homoserine kinase (thrB) CSB-YP421910EJD
CSB-EP421910EJD
CSB-BP421910EJD
CSB-MP421910EJD
CSB-EP421910EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Non-specific ribonucleoside hydrolase rihC (rihC) CSB-YP421911EJD
CSB-EP421911EJD
CSB-BP421911EJD
CSB-MP421911EJD
CSB-EP421911EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Crotonobetainyl-CoA dehydrogenase (caiA) CSB-YP421912EJD
CSB-EP421912EJD
CSB-BP421912EJD
CSB-MP421912EJD
CSB-EP421912EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Bis (5'-nucleosyl)-tetraphosphatase, symmetrical CSB-YP421913EJD
CSB-EP421913EJD
CSB-BP421913EJD
CSB-MP421913EJD
CSB-EP421913EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 3-isopropylmalate dehydratase large subunit (leuC) CSB-YP421914EJD
CSB-EP421914EJD
CSB-BP421914EJD
CSB-MP421914EJD
CSB-EP421914EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O139:H28 Iron--sulfur cluster insertion protein ErpA (erpA) CSB-YP421915EJD
CSB-EP421915EJD
CSB-BP421915EJD
CSB-MP421915EJD
CSB-EP421915EJD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>